This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Stress Urinary Incontinence
and you are
between 20 and 79
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the efficacy and safety of TAS-303 in female patients with stress urinary incontinence.

Provided treatments

  • Drug: TAS-303
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02906683. The sponsor of the trial is Taiho Pharmaceutical Co., Ltd. and it is looking for 256 volunteers for the current phase.
Official trial title:
A Phase IIa Study of TAS-303 in Female Patients With Stress Urinary Incontinence